AnterogenCoLtd Current Valuation vs. Cash Flow From Operations
| 065660 Stock | KRW 15,230 30.00 0.20% |
For AnterogenCoLtd profitability analysis, we use financial ratios and fundamental drivers that measure the ability of AnterogenCoLtd to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well AnterogenCoLtd utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between AnterogenCoLtd's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of AnterogenCoLtd over time as well as its relative position and ranking within its peers.
AnterogenCoLtd |
AnterogenCoLtd Cash Flow From Operations vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining AnterogenCoLtd's current stock value. Our valuation model uses many indicators to compare AnterogenCoLtd value to that of its competitors to determine the firm's financial worth. AnterogenCoLtd is the top company in current valuation category among its peers. It is rated third in cash flow from operations category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value AnterogenCoLtd by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for AnterogenCoLtd's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.AnterogenCoLtd Current Valuation vs. Competition
AnterogenCoLtd is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Pharmaceuticals industry is presently estimated at about 1.31 Trillion. AnterogenCoLtd totals roughly 836.51 Billion in current valuation claiming about 64% of equities listed under Pharmaceuticals industry.
AnterogenCoLtd Cash Flow From Operations vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
AnterogenCoLtd |
| = | 836.51 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.
AnterogenCoLtd |
| = | (3.05 B) |
Operating Cash Flow shows the difference between reported income and actual cash flows of the company. If a firm does not have enough cash or cash equivalents to cover its current liabilities, then both investors and management should be concerned about the company having enough liquid resources to meet current and long term debt obligations.
AnterogenCoLtd Cash Flow From Operations Comparison
AnterogenCoLtd is currently under evaluation in cash flow from operations category among its peers.
AnterogenCoLtd Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in AnterogenCoLtd, profitability is also one of the essential criteria for including it into their portfolios because, without profit, AnterogenCoLtd will eventually generate negative long term returns. The profitability progress is the general direction of AnterogenCoLtd's change in net profit over the period of time. It can combine multiple indicators of AnterogenCoLtd, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
,Ltd., a bio-venture company, engages in the research, development, and commercialization of stem cell therapy products using adipose-derived stem cells in South Korea and internationally. ,Ltd. was founded in 2000 and is headquartered in Seoul, South Korea. ANTEROGEN is traded on Korean Securities Dealers Automated Quotations in South Korea.
AnterogenCoLtd Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on AnterogenCoLtd. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of AnterogenCoLtd position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the AnterogenCoLtd's important profitability drivers and their relationship over time.
Use AnterogenCoLtd in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if AnterogenCoLtd position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnterogenCoLtd will appreciate offsetting losses from the drop in the long position's value.AnterogenCoLtd Pair Trading
AnterogenCoLtd Pair Trading Analysis
The ability to find closely correlated positions to AnterogenCoLtd could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace AnterogenCoLtd when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back AnterogenCoLtd - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling AnterogenCoLtd to buy it.
The correlation of AnterogenCoLtd is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as AnterogenCoLtd moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if AnterogenCoLtd moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for AnterogenCoLtd can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your AnterogenCoLtd position
In addition to having AnterogenCoLtd in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Mid Cap ETFs Thematic Idea Now
Mid Cap ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Mid Cap ETFs theme has 70 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Mid Cap ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in AnterogenCoLtd Stock
To fully project AnterogenCoLtd's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of AnterogenCoLtd at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include AnterogenCoLtd's income statement, its balance sheet, and the statement of cash flows.